The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Open accessAbstract
Alternative splicing of mRNA precursors is a nearly ubiquitous and extremely flexible point of gene control in humans. It provides cells with the opportunity to create protein isoforms of differing, even opposing, functions from a single gene. Cancer cells often take advantage of this flexibility to produce proteins that promote growth and survival. Many of the isoforms produced in this manner are developmentally regulated and are preferentially re-expressed in tumors. Emerging insights into this process indicate that pathways that are frequently deregulated in cancer often play important roles in promoting aberrant splicing, which in turn contributes to all aspects of tumor biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V. B., Wong, E., Orlov, Y. L., Zhang, W., Jiang, J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.043 · Cited by 2,501
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Expansion of the eukaryotic proteome by alternative splicing
Nilsen, T. W., & Graveley, B. R. (2010) · Nature · doi:10.1038/nature08909 · Cited by 2,197
Isolation and characterization
Turksen, K. (2006) · Humana Press eBooks · Cited by 2,146
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
hnRNP PROTEINS AND THE BIOGENESIS OF mRNA
Dreyfuss, G., Matunis, M. J., Pinol-Roma, S., & Burd, C. G. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.001445 · Cited by 1,560
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395 · cited 1×
“Like hnRNP A/B proteins, PTB is expressed throughout development, then downregulated in many adult tissues, most notably brain and muscle (Boutz et al. 2007a; Makeyev et al. 2007).”
BackgroundRac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Chen, M., & Manley, J. L. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2777 · Cited by 1,284
Self-citationKedersha, N. L., Gupta, M., Li, W., Miller, I., & Anderson, P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1431 · Cited by 1,256
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Self-citationCooper, T. A., Wan, L., & Dreyfuss, G. (2009) · Cell · doi:10.1016/j.cell.2009.02.011 · Cited by 1,159
Regulation of Alternative Splicing by Histone Modifications
Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M., & Misteli, T. (2010) · Science · doi:10.1126/science.1184208 · Cited by 1,109
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Tumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 946
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Barash, Y., Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. J., & Frey, B. J. (2010) · Nature · doi:10.1038/nature09000 · Cited by 895
An essential role for Rac in Ras transformation
Qiu, R.-G., Chen, J., Kirn, D., McCormick, F., & Symons, M. (1995) · Nature · doi:10.1038/374457a0 · Cited by 882
Wang, L., Miura, M., Bergeron, L., Zhu, H., & Yuan, J. (1994) · Cell · doi:10.1016/s0092-8674(94)90422-7 · Cited by 836
Translational control in cancer
Silvera, D., Formenti, S. C., & Schneider, R. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2824 · Cited by 821
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Ceramide in apoptosis: an overview and current perspectives
Pettus, B. J., Chalfant, C. E., & Hannun, Y. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00331-1 · Cited by 788
RNA processing and its regulation: global insights into biological networks
Licatalosi, D. D., & Darnell, R. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2673 · Cited by 763
Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
Mayeda, A., & Krainer, A. R. (1992) · Cell · doi:10.1016/0092-8674(92)90477-t · Cited by 735
Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K
Keely, P. J., Westwick, J. K., Whitehead, I. P., Der, C. J., & Parise, L. V. (1997) · Nature · doi:10.1038/37656 · Cited by 732
The superfamily of arginine/serine-rich splicing factors.
Fu, X. (1995) · Europe PMC (PubMed Central) · Cited by 676
SR proteins and splicing control.
Manley, J. L., & Tacke, R. (1996) · Genes & Development · doi:10.1101/gad.10.13.1569 · Cited by 671
Self-citationAberrant and Alternative Splicing in Cancer
Venables, J. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1910 · Cited by 634
Regulation of Apoptosis by Alternative Pre-mRNA Splicing
Schwerk, C., & Schulze-Osthoff, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.026 · Cited by 594
Diverse molecular functions of Hu proteins
Hinman, M. N., & Lou, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8252-6 · Cited by 587
Colwill, K., Pawson, T., Andrews, B., Prasad, J., Manley, J. L., Bell, J. C., & Duncan, P. I. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00357.x · Cited by 580
Self-citationDiagnosing and exploiting cancer's addiction to blocks in apoptosis
Letai, A. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2297 · Cited by 580
ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing
Warzecha, C. C., Sato, T. K., Nabet, B., Hogenesch, J. B., & Carstens, R. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.025 · Cited by 579
Boutz, P. L., Stoilov, P., Li, Q., Lin, C.-H., Chawla, G., Ostrow, K., Shiue, L., Ares, M., & Black, D. L. (2007) · Genes & Development · doi:10.1101/gad.1558107 · Cited by 577
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a
Guil, S., & Cáceres, J. F. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1250 · Cited by 567
(2002) · PubMed · Cited by 550
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
Kashima, T., & Manley, J. L. (2003) · Nature Genetics · doi:10.1038/ng1207 · Cited by 546
Self-citationAn RNA map predicting Nova-dependent splicing regulation
Ule, J., Stefani, G., Mele, A., Ruggiu, M., Wang, X., Taneri, B., Gaasterland, T., Blencowe, B. J., & Darnell, R. B. (2006) · Nature · doi:10.1038/nature05304 · Cited by 537
Alt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., & Lacal, J. C. (1997) · Genes & Development · doi:10.1101/gad.11.4.463 · Cited by 519
CD44 is required for two consecutive steps in HGF/c-Met signaling
Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Harper, S. J., & Bates, D. O. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2505 · Cited by 514
TIA-1 is a translational silencer that selectively regulates the expression of TNF-α
Piecyk, M., Wax, S., Beck, A. R. P., Kedersha, N., Gupta, M., Maritim, B., Chen, S., Gueydan, C., Kruys, V., Streuli, M., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4154 · Cited by 509
Burd, C. G., & Dreyfuss, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06369.x · Cited by 488
Xue, Y., Zhou, Y., Wu, T., Zhu, T., Ji, X., Kwon, Y.-S., Zhang, C., Yeo, G., Black, D. L., Sun, H., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.003 · Cited by 469
Signal-dependent regulation of splicing via phosphorylation of Sam68
Matter, N., Herrlich, P., & König, H. (2002) · Nature · doi:10.1038/nature01153 · Cited by 458
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation
Wang, W., Caldwell, M. C., Lin, S., Furneaux, H., & Gorospe, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.10.2340 · Cited by 446
Clower, C. V., Chatterjee, D., Wang, Z., Cantley, L. C., Vander Heiden, M. G., & Krainer, A. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914845107 · Cited by 424
Shepard, P. J., & Hertel, K. J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-10-242 · Cited by 416
Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S., & McKeehan, W. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4513 · Cited by 403
Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44
Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., & Zöller, M. (1992) · Science · doi:10.1126/science.1496383 · Cited by 403
Alternate splicing produces a novel cyclin D1 transcript.
Betticher, D., Thatcher, N., Altermatt, H. J., Hoban, P. R., Ryder, W. D. J., & Heighway, J. (1995) · PubMed · Cited by 399
Cascino, I., Fiucci, G., Papoff, G., & Ruberti, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2706 · Cited by 397
Role of Rac1 and Oxygen Radicals in Collagenase-1 Expression Induced by Cell Shape Change
Kheradmand, F., Werner, E., Tremble, P., Symons, M., & Werb, Z. (1998) · Science · doi:10.1126/science.280.5365.898 · Cited by 391
Cell Motility Is Controlled by SF2/ASF through Alternative Splicing of the Ron Protooncogene
Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P. M., Green, M. R., Riva, S., & Biamonti, G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.026 · Cited by 389
Tian, Q., Streuli, M., Saito, H., Schlossman, S. F., & Anderson, P. (1991) · Cell · doi:10.1016/0092-8674(91)90536-8 · Cited by 382
Kim, J.-W., Zeller, K. I., Wang, Y., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5923-5936.2004 · Cited by 371
Regulation of Fas Alternative Splicing by Antagonistic Effects of TIA-1 and PTB on Exon Definition
Izquierdo, J. M., Majós, N., Bonnal, S., Martínez, C., Castelo, R., Guigó, R., Bilbao, D., & Valcárcel, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.015 · Cited by 364
Cyclin D1: polymorphism, aberrant splicing and cancer risk
Knudsen, K. E., Diehl, J. A., Haiman, C. A., & Knudsen, E. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209371 · Cited by 363
A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins): Table 1.
Manley, J. L., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1934910 · Cited by 355
Self-citationRac1 GTPase: A “Rac” of All Trades
Bosco, E. E., Mulloy, J. C., & Zheng, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8552-x · Cited by 350
Over- and under-expressed microRNAs in human colorectal cancer
Mori (2009) · International Journal of Oncology · doi:10.3892/ijo_00000233 · Cited by 348
Schnelzer, A., Prechtel, D., Knaus, U., Dehne, K., Gerhard, M., Graeff, H., Harbeck, N., Schmitt, M., & Lengyel, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203621 · Cited by 347
Cancer-associated regulation of alternative splicing
Venables, J. P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1608 · Cited by 342
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
Chalfant, C. E., Rathman, K., Pinkerman, R. L., Wood, R. E., Obeid, L. M., Ogretmen, B., & Hannun, Y. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112010200 · Cited by 337
Aerobic glycolysis during lymphocyte proliferation
WANG, T., MARQUARDT, C., & FOKER, J. (1976) · Nature · doi:10.1038/261702a0 · Cited by 334
The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x
Paronetto, M. P., Achsel, T., Massiello, A., Chalfant, C. E., & Sette, C. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701005 · Cited by 334
Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein
Sawicka, K., Bushell, M., Spriggs, K. A., & Willis, A. E. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360641 · Cited by 332 · cited 1×
“The translational activity of PTBwas shown to be important for the up-regulation of translation of a subset of apoptotic mRNAs upon the induction of TRAIL-induced apoptosis (Sawicka et al. 2008).”
BackgroundMarkovtsov, V., Nikolic, J. M., Goldman, J. A., Turck, C. W., Chou, M.-Y., & Black, D. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7463-7479.2000 · Cited by 311
MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development
Boutz, P. L., Chawla, G., Stoilov, P., & Black, D. L. (2007) · Genes & Development · doi:10.1101/gad.1500707 · Cited by 304
Unbalanced alternative splicing and its significance in cancer
Venables, J. P. (2006) · BioEssays · doi:10.1002/bies.20390 · Cited by 299
The Apoptosis-Promoting Factor TIA-1 Is a Regulator of Alternative Pre-mRNA Splicing
Förch, P., Puig, O., Kedersha, N., Martínez, C., Granneman, S., Séraphin, B., Anderson, P., & Valcárcel, J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00107-6 · Cited by 284
Role of the RNA-binding protein HuR in colon carcinogenesis
de Silanes, I. L., Fan, J., Yang, X., Zonderman, A. B., Potapova, O., Pizer, E. S., & Gorospe, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206862 · Cited by 282
LaBranche, H., Dupuis, S., Ben-David, Y., Bani, M.-R., Wellinger, R. J., & Chabot, B. (1998) · Nature Genetics · doi:10.1038/575 · Cited by 280
Intronic Sequences Flanking Alternatively Spliced Exons Are Conserved Between Human and Mouse
Sorek, R., & Ast, G. (2003) · Genome Research · doi:10.1101/gr.1208803 · Cited by 278
The Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1
Michlewski, G., Sanford, J. R., & Cáceres, J. F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.013 · Cited by 277
Wang, E., Miller, L. D., Ohnmacht, G. A., D, S. M. M., Pérez‐Díez, A., Petersen, D. W., Zhao, Y., Simon, R., Powell, J. I., Asaki, E., et al. (2002) · PubMed · Cited by 260
Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors
Jordan, P., Brazão, R., Boavida, M. G., Gespach, C., & Chastre, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203233 · Cited by 253
Expression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., & Takahashi, H. (2001) · Hepatology · doi:10.1053/jhep.2001.25387 · Cited by 246
Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT
Blaustein, M., Pelisch, F., Tanos, T., Muñoz, M. J., Wengier, D., Quadrana, L., Sanford, J. R., Muschietti, J. P., Kornblihtt, A. R., Cáceres, J. F., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1020 · Cited by 246
Yamaguchi, F., Saya, H., Bruner, J. M., & Morrison, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.484 · Cited by 245
An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu, F., Gladden, A. B., & Diehl, J. A. (2003) · PubMed · Cited by 239
Promoter usage and alternative splicing
Kornblihtt, A. R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.04.014 · Cited by 236
HuR: Post-Transcriptional Paths to Malignancy
Silanes, I. L. D., Lal, A., & Gorospe, M. (2005) · RNA Biology · doi:10.4161/rna.2.1.1552 · Cited by 231
Identification and Functional Outcome of mRNAs Associated with RNA-Binding Protein TIA-1
López de Silanes, I., Galbán, S., Martindale, J. L., Yang, X., Mazan-Mamczarz, K., Indig, F. E., Falco, G., Zhan, M., & Gorospe, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9520-9531.2005 · Cited by 230
The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites
Forch, P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf668 · Cited by 228
Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA Splicing
Martinez-Contreras, R., Fisette, J.-F., Nasim, F.-U. H., Madden, R., Cordeau, M., & Chabot, B. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040021 · Cited by 226
Nowak, D. G., Amin, E. M., Rennel, E. S., Hoareau-Aveilla, C., Gammons, M., Damodoran, G., Hagiwara, M., Harper, S. J., Woolard, J., Ladomery, M. R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074930 · Cited by 226
hnRNP A1 Recruited to an Exon In Vivo Can Function as an Exon Splicing Silencer
Del Gatto-Konczak, F., Olive, M., Gesnel, M.-C., & Breathnach, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.251 · Cited by 224
Solomon, D. A., Wang, Y., Fox, S. R., Lambeck, T. C., Giesting, S., Lan, Z., Senderowicz, A. M., & Knudsen, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303969200 · Cited by 218
Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR
Doller, A., Pfeilschifter, J., & Eberhardt, W. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.007 · Cited by 215
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
Rybak, J.-N., Roesli, C., Kaspar, M., Villa, A., & Neri, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1436 · Cited by 212
Zhou, Y.-Q., He, C., Chen, Y.-Q., Wang, D., & Wang, M.-H. (2003) · Oncogene · doi:10.1038/sj.onc.1206075 · Cited by 210
Targeting the HGF/Met signalling pathway in cancer
Cecchi, F., Rabe, D. C., & Bottaro, D. P. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.028 · Cited by 209
Alternative splicing in cancer: Noise, functional, or systematic?
Skotheim, R. I., & Nees, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.016 · Cited by 208
Olopade, O. I., Adeyanju, M., Safa, A. R., Hagos, F., Mick, R., Thompson, C. B., & Recant, W. M. (1997) · PubMed · Cited by 203
Blanchette, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1939 · Cited by 203
Gatto–Konczak, F. D., Bourgeois, C. F., Guiner, C. L., Kister, L., Gesnel, M.-C., Stévenin, J., & Breathnach, R. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6287-6299.2000 · Cited by 202
Regulation of CD44 Alternative Splicing by SRm160 and Its Potential Role in Tumor Cell Invasion
Cheng, C., & Sharp, P. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.362-370.2006 · Cited by 201
Bcl-xS Antagonizes the Protective Effects of Bcl-xL
Minn, A. J., Boise, L. H., & Thompson, C. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6306 · Cited by 197
RNA-binding protein TIAR is essential for primordial germ cell development
Beck, A. R. P., Miller, I. J., Anderson, P., & Streuli, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2331 · Cited by 195
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Wu, H., Sun, S., Tu, K., Gao, Y., Xie, B., Krainer, A. R., & Zhu, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.021 · Cited by 191
CD95, BIM and T cell homeostasis
Bouillet, P., & O'Reilly, L. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2570 · Cited by 190
Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer
Carstens, R. P., Eaton, J. V., Krigman, H. R., Walther, P. J., & Garcia-Blanco, M. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201498 · Cited by 188
Translational Control of Cytochrome c by RNA-Binding Proteins TIA-1 and HuR
Kawai, T., Lal, A., Yang, X., Galban, S., Mazan-Mamczarz, K., & Gorospe, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3295-3307.2006 · Cited by 187
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway
Weg-Remers, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4194 · Cited by 184
Alternative Splicing and Tumor Progression
Ghigna, C., Valacca, C., & Biamonti, G. (2008) · Current Genomics · doi:10.2174/138920208786847971 · Cited by 181
The emerging role of splicing factors in cancer
Grosso, A. R., Martins, S., & Carmo‐Fonseca, M. (2008) · EMBO reports · doi:10.1038/embor.2008.189 · Cited by 179
Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein
Xie, J., Lee, J.-A., Kress, T. L., Mowry, K. L., & Black, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432696100 · Cited by 178
Collesi, C., Santoro, M. M., Gaudino, G., & Comoglio, P. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5518 · Cited by 176
RBM5/Luca-15/H37 Regulates Fas Alternative Splice Site Pairing after Exon Definition
Bonnal, S., Martínez, C., Förch, P., Bachi, A., Wilm, M., & Valcárcel, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.008 · Cited by 176
Mercatante, D. R., Mohler, J. L., & Kole, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209236200 · Cited by 174
Singh, A., Karnoub, A. E., Palmby, T. R., Lengyel, E., Sondek, J., & Der, C. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208182 · Cited by 174
A tumor suppressor function for caspase-2
Ho, L. H., Taylor, R., Dorstyn, L., Cakouros, D., Bouillet, P., & Kumar, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811928106 · Cited by 167
Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Protein Sam68
Paronetto, M. P., Cappellari, M., Busà, R., Pedrotti, S., Vitali, R., Comstock, C., Hyslop, T., Knudsen, K. E., & Sette, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2788 · Cited by 167
FAS Activation Induces Dephosphorylation of SR Proteins
Chalfant, C. E., Ogretmen, B., Galadari, S., Kroesen, B.-J., Pettus, B. J., & Hannun, Y. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106291200 · Cited by 163
Antiapoptotic function of RNA‐binding protein HuR effected through prothymosin α
Lal, A., Kawai, T., Yang, X., Mazan‐Mamczarz, K., & Gorospe, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600661 · Cited by 162
Identification of an aptamer targeting hnRNP A1 by tissue slide‐based SELEX
Li, S., Xu, H., Ding, H., Huang, Y., Cao, X., Yang, G., Li, J., Xie, Z., Meng, Y., Li, X., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2543 · Cited by 161
hnRNP A1 associates with telomere ends and stimulates telomerase activity
Zhang, Q.-S., Manche, L., Xu, R.-M., & Krainer, A. R. (2006) · RNA · doi:10.1261/rna.58806 · Cited by 160
Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator
Konig, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2904 · Cited by 159
Denkert, C., Weichert, W., Pest, S., Koch, I., Licht, D., Köbel, M., Reles, A., Sehouli, J., Dietel, M., & Hauptmann, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1987 · Cited by 159
Multiple and Specific mRNA Processing Targets for the Major Human hnRNP Proteins
Venables, J. P., Koh, C.-S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L., Bramard, A., Paquet, E. R., Watier, V., Durand, M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00726-08 · Cited by 158
Wang, F., Kan, M., Yan, G.-C., Xu, J.-M., & Mckeehan, W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10231 · Cited by 157
Kawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson-Welsh, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6577 · Cited by 156
Izquierdo, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800017200 · Cited by 156
Carstens, R. P., Wagner, E. J., & García-Blanco, M. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7388-7400.2000 · Cited by 156
A comprehensive biochemical and genetic analysis of the yeast U1 snRNP reveals five novel proteins.
GOTTSCHALK, A. R., Tang, J., Puig, Ó., Salgado, J., Neubauer, G., Colot, H. V., Mann, M., Séraphin, B., Rosbash, M., Lührmann, R., et al. (1998) · Europe PMC (PubMed Central) · Cited by 155
Alternative Splicing of Rac1 Generates Rac1b, a Self-activating GTPase
Fiegen, D., Haeusler, L. C., Blumenstein, L., Herbrand, U., Dvorský, R., Vetter, I. R., & Ahmadian, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310281200 · Cited by 155
Met‐Related Receptor Tyrosine Kinase Ron in Tumor Growth and Metastasis
Wagh, P. K., Peace, B. E., & Waltz, S. E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00001-8 · Cited by 154
Pino, I. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00193-4 · Cited by 154
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines
Cheung, H., Hai, T., Zhu, W., Baggerly, K., Tsavachidis, S., Krahe, R., & Cote, G. J. (2009) · Brain · doi:10.1093/brain/awp153 · Cited by 153
Patry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Wellinger, R. J., & Chabot, B. (2003) · PubMed · Cited by 152
Patel, N. A., Kaneko, S., Apostolatos, H. S., Bae, S. S., Watson, J. E., Davidowitz, K., Chappell, D. S., Birnbaum, M. J., Cheng, J. Q., & Cooper, D. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411485200 · Cited by 150
A positive feedback loop couples Ras activation and CD44 alternative splicingPreprint
Cheng, C., Yaffe, M. B., & Sharp, P. A. (2006) · Genes & Development · doi:10.1101/gad.1430906 · Cited by 144
Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
Jiang, Z., Zhang, W., Rao, Y., & Wu, J. Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9155 · Cited by 143
Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?
Kumar, S. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2745 · Cited by 142
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5
Fushimi, K., Ray, P., Kar, A. N., Wang, L., Sutherland, L. C., & Wu, J. Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805569105 · Cited by 140
hnRNP H and hnRNP F Complex with Fox2 To Silence Fibroblast Growth Factor Receptor 2 Exon IIIc
Mauger, D., Lin, C. P., & García-Blanco, M. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00739-08 · Cited by 139
Long lifespan in worms with long telomeric DNA
Joeng, K. S., Song, E. J., Lee, K., & Lee, J. (2004) · Nature Genetics · doi:10.1038/ng1356 · Cited by 138
An intronic element contributes to splicing repression in spinal muscular atrophy
Kashima, T., Rao, N., & Manley, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700343104 · Cited by 137
Self-citationCohen, J. B., & Levinson, A. D. (1988) · Nature · doi:10.1038/334119a0 · Cited by 134
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
Pritchard‐Jones, R., Dunn, D., Qiu, Y., Varey, A. H. R., Orlando, A., Rigby, H., Harper, S. J., & Bates, D. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603839 · Cited by 133
Lu, Y., Yao, H., & Wang, M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.007 · Cited by 132
Shi, Y., Reddy, B. D., & Manley, J. L. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.022 · Cited by 131
Self-citationMitchell, S. A., Spriggs, K. A., Bushell, M., Evans, J. R., Stoneley, M., Quesne, J. P. C. L., Spriggs, R. V., & Willis, A. E. (2005) · Genes & Development · doi:10.1101/gad.339105 · Cited by 130
Roles of hnRNP A1, SR Proteins, and p68 Helicase in c-H-ras Alternative Splicing Regulation
Guil, S., Gattoni, R. C., Carrascal, M., Abián, J., Stévenin, J., & Bach‐Elias, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2927-2941.2003 · Cited by 130
Jo, O. D., Martin, J., Bernath, A., Masri, J., Lichtenstein, A. K., & Gera, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801185200 · Cited by 127
He, X., Pool, M. D., Darcy, K. M., Lim, S. B., Auersperg, N., Coon, J. S., & Beck, W. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210307 · Cited by 127
The splicing-factor oncoprotein SF2/ASF activates mTORC1
Karni, R., Hippo, Y., Lowe, S. W., & Krainer, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801376105 · Cited by 125
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
Burd, C. J., Petre, C. E., Morey, L. M., Wang, Y., Revelo, M. P., Haiman, C. A., Lu, S., Fenoglio‐Preiser, C. M., Li, J., Knudsen, E. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506281103 · Cited by 125
Manabe, R., Oh-e, N., & Sekiguchi, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5919 · Cited by 117
Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation
He, Y., Brown, M. A., Rothnagel, J. A., Saunders, N. A., & Smith, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02448 · Cited by 117
Gonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 116
Oltean, S., Sorg, B. S., Albrecht, T. R., Bonano, V. I., Brazas, R. M., Dewhirst, M. W., & García-Blanco, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603090103 · Cited by 114
Merdzhanova, G., Edmond, V., Seranno, S. D., Broeck, A. V. D., Corcos, L., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.135 · Cited by 113
Cobbold, L. C., Wilson, L. A., Sawicka, K., King, H. A., Kondrashov, A. V., Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Oncogene · doi:10.1038/onc.2010.31 · Cited by 112
Regulation of Bcl-2 Expression by HuR in HL60 Leukemia Cells and A431 Carcinoma Cells
Ishimaru, D., Ramalingam, S., Sengupta, T. K., Bandyopadhyay, S., Dellis, S., Tholanikunnel, B. G., Fernandes, D., & Spicer, E. K. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0476 · Cited by 111
Sendai virus trailer RNA binds TIAR, a cellular protein involved in virus‐induced apoptosis
Iseni, F., Garcin, D., Nishio, M., Kedersha, N., Anderson, P., & Kolakofsky, D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf513 · Cited by 109
Blaxall, B. C., Dwyer‐Nield, L. D., Bauer, A. K., Bohlmeyer, T. J., Malkinson, A. M., & Port, J. D. (2000) · Molecular Carcinogenesis · Cited by 108
Bardella, C., Costa, B., Maggiora, P., Patane’, S., Olivero, M., Ranzani, G. N., Bortoli, M. D., Comoglio, P. M., & Renzo, M. F. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0600 · Cited by 108
Expression of the H-ras proto-oncogene is controlled by alternative splicing
Cohen, J. B., Broz, S. D., & Levinson, A. D. (1989) · Cell · doi:10.1016/0092-8674(89)90427-3 · Cited by 105
Sanchez, G., Bittencourt, D., Laud, K., Barbier, J., Delattre, O., Auboeuf, D., & Dutertre, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710748105 · Cited by 104
Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia
Liu, J. H., Wei, S., Lamy, T., Li, Y., Epling‐Burnette, P. K., Djeu, J. Y., & Loughran, T. P. (2002) · Blood · doi:10.1182/blood.v100.4.1449.h81602001449_1449_1453 · Cited by 102
Massiello, A., Roesser, J. R., & Chalfant, C. E. (2006) · The FASEB Journal · doi:10.1096/fj.05-5021fje · Cited by 101
Zhou, J. M., Allred, D. C., Avis, I. M., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010631915831 · Cited by 99
Beck, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.19.3829 · Cited by 97
Predominant expression of the long isoform of Bcl‐x (Bcl‐xL) in human lymphomas
Xerri, L., Parc, P., Brousset, P., Schlaifer, D., Hassoun, J., Reed, J. C., Krajewski, S., & Birnbaum, D. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.423958.x · Cited by 94
Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
Comstock, C. E. S., Augello, M. A., Benito, R. P., Karch, J. M., Tran, T. H., Utama, F. E., Tindall, E. A., Wang, Y., Burd, C. J., Groh, E. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2865 · Cited by 94
Sam68 exerts separable effects on cell cycle progression and apoptosis
Taylor, S. J., Resnick, R. J., & Shalloway, D. I. (2004) · BMC Cell Biology · doi:10.1186/1471-2121-5-5 · Cited by 93
Wang, D., Shen, Q., Chen, Y., & Wang, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207282 · Cited by 91
RBM5 as a Putative Tumor Suppressor Gene for Lung Cancer
Sutherland, L. C., Wang, K., & Robinson, A. G. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c6e330 · Cited by 91
Babić, I., Cherry, E., & Fujita, D. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209504 · Cited by 89
hnRNP A2 Regulates Alternative mRNA Splicing of TP53INP2 to Control Invasive Cell Migration
Moran‐Jones, K., Grindlay, J., Jones, M. D., Smith, R., & Norman, J. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1852 · Cited by 88
Knoch, K.-P., Meisterfeld, R., Kersting, S., Bergert, H., Altkrüger, A., Wegbrod, C., Jäger, M., Saeger, H., & Solimena, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.12.008 · Cited by 84
Izquierdo, J. M., & Valcárcel, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600198200 · Cited by 84
Yan-Sanders, Y., Hammons, G., & Lyn‐Cook, B. D. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00168-4 · Cited by 83
Cho, S., Kim, J. H., Back, S. H., & Jang, S. K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1283-1297.2005 · Cited by 81
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
Olshavsky, N. A., Comstock, C. E. S., Schiewer, M. J., Augello, M. A., Hyslop, T., Sette, C., Zhang, J., Parysek, L. M., & Knudsen, K. E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3468 · Cited by 77
Wang, Y., Dean, J. L., Millar, E. K. A., Tran, T. H., McNeil, C. M., Burd, C. J., Henshall, S. M., Utama, F. E., Witkiewicz, A. K., Rui, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3170 · Cited by 76
Elucidation of a C-Rich Signature Motif in Target mRNAs of RNA-Binding Protein TIAR
Kim, H. S., Kuwano, Y., Zhan, M., Pullmann, R., Mazan-Mamczarz, K., Li, H., Kedersha, N., Anderson, P., Wilce, M. C. J., Gorospe, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01036-07 · Cited by 75
The β-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression
Gonçalves, V., Matos, P., & Jordan, P. (2008) · RNA · doi:10.1261/rna.1253408 · Cited by 75
Cited by
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Lee, Y., & Rio, D. C. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034316 · Cited by 1,291
Scotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
Protein arginine methyltransferases and cancer
Yang, Y., & Bedford, M. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3409 · Cited by 1,083
Metadata
- Authors
- David, C. J., & Manley, J. L.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-11-01
- Volume
- 24
- Issue
- 21
- Pages
- 2343-2364
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2157936723
- Cited by
- 814
- References
- 227
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.